Prediabetes screening: Questionable benefits in the golden years

Metabol Open. 2021 Apr 7:10:100091. doi: 10.1016/j.metop.2021.100091. eCollection 2021 Jun.

Abstract

Irrespective of the definition and diagnostic criteria used, the term prediabetes denotes a state of dysmetabolism with a high risk of progression to diabetes mellitus. Although diabetes-related complications may already be evident among individuals with prediabetes, interventions at this stage primarily aim to hinder the development of overt hyperglycemia rather than to prevent complications. Current recommendations for prediabetes testing are common across all adult age categories. Recent evidence arising from the prospective investigation of the natural course of prediabetes among elderly individuals pose questions regarding the benefits of meticulous prediabetes screening in this age group. In view of this and due to the lack of sufficient data to concretely support a positive impact of further preventive strategies among older individuals, screening recommendations should be reevaluated to target selected elderly individuals who are most likely to benefit in terms of quality of life and prognosis. Further therapeutic measures should be tailored to the inherent features of this frail age group, in order to exert a meaningful effect on overall health status.

Keywords: ADA, American Diabetes Association; BMI, Body Mass Index; CVD, Cardiovascular disease; DCCT, Diabetes Control and Complications Trial; DM, Diabetes mellitus; Diabetes; FPG, Fasting plasma glucose; Glucose; Glycated hemoglobin; HIV, Human immunodeficiency virus; HbA1c, Glycated hemoglobin; IEC, International Expert Committee; NGSP, National Glycohemoglobin Standardization Program; PG, Plasma glucose; Prediabetes; Screening; WHO, World Health Organization; oGTT, oral glucose tolerance test.

Publication types

  • Editorial